Disclosure Summit: Agenda: Day II

DISCLOSURE SUMMIT AGENDA DAY II: HOW TO ESTABLISH EFFECTIVE DISCLOSURE PROTOCOLS AND AGGREGATE SPEND PROGRAMS Friday, March 5, 2010
PART II: DISCLOSURE PROTOCOLS AND AGGREGATE SPEND PROGRAMS (CONTINUED)
8:00 am	Welcome and Introduction to Day Two Jack T. Tanselle Director, Navigant Consulting, Inc., Chicago, IL (Co chair) Michael Varlotta Senior Director, Department of Medical Education, Medical Affairs, Centocor, a wholly owned subsidiary of Johnson & Johnson, Horsham, PA (Co chair)
8:15 am	Auditing and Monitoring Your Aggregate Spend Program Sarah K. Giesting, Esq. Associate, Epstein Becker & Green, New York, NY Heather Reilly Powell, Esq. Director, Compliance Training and Reporting, Daiichi Sankyo, Inc., Former Associate Director, Global Compliance, Cephalon, Inc., Parsippany, NJ Presentation Material (Acrobat)
9:00 am	Applying Business Process Management Strategies to Improve Aggregate Spend Reporting Jennifer Colapietro Director, PricewaterhouseCoopers Pharmaceutical and Life Sciences Advisory Services, Florham Park, NJ Presentation Material (Acrobat)
9:30 am	Break
10:00 am	Aggregate Spend Disclosure Strategy: Utilizing a Gap Analysis to Advance an Aggregate Spend Program Marci Juneau Manager, Life Sciences Advisory Services, Huron Consulting Group, Atlanta, GA Rore Middleton Corporate Compliance Consultant, Purdue Pharma, Stamford, CT Paul J. Silver Managing Director, Huron Consulting Group, LLC, Atlanta, GA Presentation Material (Acrobat)
10:45 am	Aggregate Spend Technology Solutions Roundtable Michael Bell, Esq. President, R-Squared, Princeton, NJ Mitch Chi Senior Vice President, Sales, Health Market Science, King of Prussia, PA Presentation Material (Acrobat) John Patrick Oroho, Esq. Executive Vice President, Porzio Pharmaceutical Services, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ Presentation Material (Acrobat) Don Soong Senior Director, Compliance Solutions Development, Cegedim Dendrite, Bedminster, NJ David Wysocky Director, PricewaterhouseCoopers Pharmaceutical and Life Sciences Advisory Services, Boston, MA Kim Life, Esq. Principal, Life Compliance Solutions, Former Associate Director, Business Conduct, Gilead Sciences, San Francisco, CA (Moderator)
12:15 pm	Networking Luncheon
1:15 pm	How to Manage New Clinical Trial Disclosure Requirements Michael N. Druckman, Esq. Partner, Hogan & Hartson, Washington, DC Presentation Material (Acrobat) Trudy J. Seeley, Esq. Compliance Manager, State Law Compliance and US Corporate Compliance, sanofi-aventis, Bridgewater, NJ Presentation Material (Acrobat)
2:00 pm	The Physician-Industry Relationship: Flaws and Solutions William M. Mandell, Esq. Partner, Pierce & Mandell, PC, Boston, MA Presentation Material (Acrobat) James Roosevelt, Jr., Esq. President and Chief Executive Officer, Tufts Health Plan, Past President, American Health Lawyers Association, Former Associate Commissioner for Retirement Policy, US Social Security Administration, Boston, MA Thomas P. Stossel, MD Director, Translational Medicine Division, Senior Physician, Hematology Division, American Cancer Society Professor of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA Frank W. LoGerfo, MD William V. McDermott Distinguished Professor of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (Moderator) Presentation Material (Acrobat)
2:45 pm	Industry Disclosure Best Practice Roundtable Jacqueline K. Huber Corporate Vice President and Chief Compliance Officer, Biomet, Inc.. Warsaw, IN Heather Reilly Powell, Esq. Director, Compliance Training and Reporting, Daiichi Sankyo, Inc., Former Associate Director, Global Compliance, Cephalon, Inc., Parsippany, NJ Trudy J. Seeley, Esq. Compliance Manager, State Law Compliance and US Corporate Compliance, sanofi-aventis, Bridgewater, NJ Michael Varlotta Senior Director, Department of Medical Education, Medical Affairs, Centocor, a wholly owned subsidiary of Johnson & Johnson, Horsham, PA Jonathon Kellerman Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ (Moderator)
3:45 pm	Summit Adjournment